GILLIS JONATHAN (CAAO and PAO) sold 27.8% of their position (69.83K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.09M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/29/2026ACC: 0001709954-26-000008
Officer· CAAO and PAO
Since Feb 2026
-69.83K
Net shares
Net seller
$2.09M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
69.83K disposed
Non-Derivative Transactions5
Voting Common Stock
Direct
Shares
−7.91K
Price / share
$28.94
Trade value
$229.03K
% of position
3.2%
4/27/2026
251.05K→243.14K
Voting Common Stock
Direct
Shares
−29.62K
Price / share
$29.60
Trade value
$876.84K
% of position
12.2%
4/27/2026
243.14K→213.52K
Voting Common Stock
Direct
Shares
−14.36K
Price / share
$30.46
Trade value
$437.50K
% of position
6.7%
4/27/2026
213.52K→199.15K
Voting Common Stock
Direct
Shares
−17.23K
Price / share
$30.33
Trade value
$522.74K
% of position
8.7%
4/28/2026
199.15K→181.92K
Voting Common Stock
Direct
Shares
−700.00
Price / share
$30.83
Trade value
$21.58K
% of position
0.4%
4/28/2026
181.92K→181.22K
Total
Net shares
−69.83K
Net value
-$2.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 4/27/2026 | S · Sale | −7.91K | $28.94 | $229.03K | 3.2% | 251.05K | 243.14K |
| Voting Common Stock Direct | 4/27/2026 | S · Sale | −29.62K | $29.60 | $876.84K | 12.2% | 243.14K | 213.52K |
| Voting Common Stock Direct | 4/27/2026 | S · Sale | −14.36K | $30.46 | $437.50K | 6.7% | 213.52K | 199.15K |
| Voting Common Stock Direct | 4/28/2026 | S · Sale | −17.23K | $30.33 | $522.74K | 8.7% | 199.15K | 181.92K |
| Voting Common Stock Direct | 4/28/2026 | S · Sale | −700.00 | $30.83 | $21.58K | 0.4% | 181.92K | 181.22K |
| Total | −69.83K | -$2.09M | ||||||
Derivative Transactions0
No derivative transactions reported